Achilles Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference

Published 07 Jan 2020

Achilles Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference

Achilles Therapeutics (“Achilles”), a biopharmaceutical company developing personalised cancer immunotherapies, today announced that Dr. Iraj Ali, Chief Executive Officer, will present at the 38th Annual J.P. Morgan Healthcare Conference on Tuesday, 14 January 2020 at 8:30 a.m. Pacific Time. The event will be held in San Francisco at the Westin St. Francis.